MetaCap

Neuphoria Therapeutics Insider Trades

NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.35+0.03 (+1.29%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Neuphoria Therapeutics insider activity

No Neuphoria Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Lynx1 Capital Management LP & Nichols Weston (10% Owner) buying 639,110 shares at $5.14 on Oct 21, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NEUP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NEUP insider transactions

Neuphoria Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 21, 2025Lynx1 Capital Management LP & Nichols Weston10% OwnerBuy639,110$3.28MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related